4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Codexis, Inc. (CDXS) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 146 employees. Its market capitalization is roughly $201 million. In the fiscal year ended 2025-12-31, CDXS reported $70M in revenue and ($44M) in net income.
Codexis, Inc.
Interactive charts & full statements → Open the CDXS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $70M | $59M | $70M | $139M | — |
| Gross Profit | $61M | $43M | $57M | $101M | — |
| Operating Income (EBIT) | ($38M) | ($58M) | ($55M) | ($32M) | — |
| Net Income | ($44M) | ($65M) | ($76M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $15M | $39M | $9M | $15M | $8M | — |
| Gross Profit | $13M | $37M | $6M | $13M | $5M | — |
| Operating Income (EBIT) | ($8M) | $14M | ($19M) | ($13M) | ($20M) | — |
| Net Income | ($9M) | $10M | ($20M) | ($13M) | ($21M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $148M | $149M | $137M | $250M | — |
| Total Liabilities | $97M | $82M | $50M | $106M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CDXS viewer.
About TickerBase · Data methodology & sources